Licensing & Royalties >> Licensing Opportunities >> Technology Abstracts   Infectious Diseases - Diagnostics: Date Ref. No. Patent No. Title 10/7/2009 E-139-2006/0 Development of Dengue Virus Type 3 Vaccine Candidates 10/7/2009 E-328-2001/1 Use of CpG Oligodeoxynucleotides to Induce Epithelial Cell Growth 9/28/2009 E-324-2004/3 In Vitro Model for Hepatitis C Virion Production 9/3/2009 E-169-2004/0 E-281-2005/0 E-318-2000/0 Rapid Diagnostic Applications of Phage 8/31/2009 E-078-2009/0 Antigenic Chimeric Tick-Borne Encephalitis Virus/Dengue Virus Type 4 Recombinant Viruses 8/14/2009 E-063-2009/0 Antigen Mixtures for Serological Detection of HHV-8 Infection 8/11/2009 E-206-2006/0 Oligo Microarray for Detection of All Known Mammalian and Avian Pathogenic Viruses 8/11/2009 E-010-1994/0 5,610,060 Isolated Helicobacter hepaticus 7/29/2009 E-205-2008/0 Novel Proteins from the Sand Fly Lutzomyia longipalpis are Potent Inhibitors of Complement Activity 7/29/2009 E-204-2008/0 Potent Anti-Coagulant Activity of a Novel Protein from the Sand Fly Lutzomyia longipalpis 7/14/2009 E-249-2007/0 A Unique Infectious Hepatitis C Virus Clone, Strain HC-TN (genotype 1a) 7/2/2009 E-152-2009/0 qPCR Assay for Detection of JC Virus 6/1/2009 E-093-2000/0 6,905,822 7,547,519 Method of Diagnosing Multidrug Resistant Tuberculosis 6/1/2009 E-114-2009/0 Axenically-Produced Coxiella burnetii and Methods for Producing Axenic Coxiella burnetii 6/1/2009 E-039-1999/0 7,115,262 A Novel Chimeric Protein for Prevention and Treatment of HIV Infection 5/4/2009 E-022-2004/0 Live-Attenuated West Nile Virus Vaccines with Improved Immune Responses 3/24/2009 E-308-2008/0 Vaccine for Shigella sonnei 2/17/2009 E-019-2009/0 Quantitative Real-Time RT-PCR Array for Detection of Human Herpesvirus 6A Gene Expression 2/2/2009 E-142-2008/0 Humanized Monoclonal Antibodies that Specifically Bind Japanese Encephalitis Virus (JEV) and Their Use 12/1/2008 E-029-2007/0 A Varicella-Zoster Virus Mutant that is Markedly Impaired for Latent Infection Available for the Development of Shingles Vaccines and Diagnostics 12/1/2008 E-240-2008/0 Detection and Quantification of HIV Antigen 12/1/2008 E-004-2004/2 7,025,961 Anti-Plasmodium Compositions and Methods of Use 12/1/2008 E-228-2002/0 Methods and Compositions for Selectively Enriching Microbes 11/1/2008 E-174-2005/0 Novel Infrared (IR)-Transparent Hydrophilic Membrane That Can be Used for Filtration, Printing or Microarrays, and Cultivation of Bacteria and Other Microorganisms for Reagent-Free IR Spectroscopic Identification 11/1/2008 E-208-2006/0 Microarray for Detection and Subtyping of Human Influenza Viruses 10/1/2008 E-204-2007/0 Methods of Glycosylation and Bioconjugation 10/1/2008 E-145-2004/3 Monoclonal Antibodies Against Orthopoxviruses 10/1/2008 E-240-2007/0 Development of Antigenic Chimeric St. Louis Encephalitis Virus/Dengue Virus Type Four Recombinant Viruses (SLEV/DEN4) as Vaccine Candidates for the Prevention of Disease Caused by SLEV 10/1/2008 E-279-2007/0 Alpha 1-3 N-Acetylgalactosaminyltransferases with Altered Donor and Acceptor Specificities, Compositions, and Methods of Use 10/1/2008 E-280-2007/0 Beta 1,4-Galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use 10/1/2008 E-066-2003/5 Monoclonal Antibodies That Bind or Neutralize Dengue Virus 10/1/2008 E-089-2002/1 7,517,531 Dengue Tetravalent Vaccine Containing a Common 30 Nucleotide Deletion in the 3'-UTR of Dengue Types 1, 2, 3, and 4 10/1/2008 E-230-2002/2 7,482,133 Catalytic Domains of [beta](1,4)-galactosyltransferase I Having Altered Donor and Acceptor Specificities, Domains That Promote In Vitro Protein Folding, and Methods for Their Use 9/1/2008 E-149-2006/2 Compositions and Methods for Increasing Recombinant Protein Yields through the Modification of Cellular Properties 9/1/2008 E-123-2007/0 E-146-2004/0 Monoclonal Antibodies that Neutralize B. anthracis Protective Antigen (PA), Lethal Factor (LF) and Edema Factor (EF) 9/1/2008 E-236-2007/3 Immunogenic Peptides Against Influenza Virus 9/1/2008 E-268-2002/0 7,261,900 Recombinant Modified Bacillus anthracis Protective Antigen for Use in Vaccines 9/1/2008 E-109-2007/1 A Rapid Ultrasensitive Assay for Detecting Prions Based on the Seeded Polymerization of Recombinant Normal Prion Protein (rPrP-sen) 9/1/2008 E-032-2008/0 Use of Saccharides Cross-Reactive with Bacillus anthracis Spore Glycoprotein as a Vaccine Against Anthrax 9/1/2008 E-016-2008/0 Modified Sugar Substrates and Methods of Use 8/1/2008 E-141-2003/0 Monoclonal Antibodies to HIV-1 Vpr 7/1/2008 E-203-2008/0 T-Cell Enumeration Using Dried Blood Spots as a Surrogate for CD4+ T-Cell Counts to Monitor HIV+ Patients 6/1/2008 E-298-2007/0 Immunostimulatory Combinations of TLR Ligands and Methods of Use 5/1/2008 E-056-2007/0 Microarray Binding Sensors Using Carbon Nanotube Transistors 4/1/2008 E-323-2007/1 Assay for Identification of Influenza-Neutralizing Antibodies 3/1/2008 E-247-2002/1 Modulators of Nuclear Hormone Receptor Activity: Novel Compounds, Diverse Applications for Infectious Diseases, Including Anthrax (B. anthracis) 2/1/2008 E-031-2006/0 Chlamydia Vaccine 10/1/2007 E-263-2005/0 Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections 6/1/2007 E-300-2002/0 Development of a Novel High Throughput Assay to Measure Cell-Infection with Vaccinia Strains Expressing Reporter Genes 2/1/2007 E-130-2001/0 7,223,844 7,378,093 Broadly Cross-Reactive Neutralizing Antibodies against Human Immunodeficiency Virus Selected by ENV-CD4-CO-Receptor Complexes 12/1/2006 E-188-2006/0 Erythroid Progenitor Cells and Methods for Producing Parvovirus B19 Therein 12/1/2006 E-252-2001/0 HIV Entry Inhibitor 11/1/2006 E-091-1999/0 2259657 6,617,103 HSV-2 Diagnostic 4/1/2006 E-194-2005/0 The Medusa™ Sequencer: A Sequencing Machine the Size of a Molecule that Could Sequence RNA in a Living Cell 11/1/2005 E-104-2005/1 Furin Inhibitors and Alpha-Defensin for Preventing Papilloma Virus Infection 11/1/2005 E-051-2005/0 Identification of a Fusion/Entry Receptor for Human Herpesvirus-8 9/1/2005 E-184-2004/0 A Novel Amplification Method Permits Pathogens to be Detected with Microarrays 8/1/2005 E-318-2000/0 Method for Determining Sensitivity to a Bacteriophage 6/1/2005 E-238-2003/0 Detection and Identification of Mycobacterium Using SecA 4/1/2005 E-022-2005/0 Methods for High-Efficiency Single Genome Sequencing of HIV 4/1/2005 E-176-2003/0 Antibodies Against the Amino Terminus Region of Circumsporozoite Protein Prevent the Onset of Malaria 3/1/2005 E-076-2004/0 An Epitope-Enhancement of Human CD4 HIV Epitope 12/1/2004 E-004-2005/0 E-004-2005/4 Human Monoclonal Antibodies Against Hendra and Nipah Viruses 12/1/2004 E-299-2004/0 Vaccines Against Crimean-Congo Hemorrhagic Fever 10/1/2004 E-049-2004/0 7,303,751 Anti-Plasmodium Compositions and Methods of Use 10/1/2004 E-259-2004/0 E-259-2004/1 HIV-1 Infection Detection Assay for Seroconverted HIV-1 Vaccine Recipients 6/1/2004 E-228-2003/1 E-228-2003/2 Soluble SARS Coronavirus Spike Protein (S Protein) 3/1/2004 E-008-1996/0 C-C Chemokines That Inhibit Retrovirus Infection 3/1/2004 E-146-2002/0 Methods and Compositions to Detect Nucleic Acid 2/1/2004 E-018-2004/0 Strand-Specific Amplification 2/1/2004 E-145-1989/0 5,242,800 Novel Receptor for Pathogenic Fungi 1/1/2004 E-041-2004/0 Codon-Optimization of the HIV-1 Vif Gene 1/1/2004 E-324-2003/0 Streptococcus Lipoprotein Antigens 1/1/2004 E-189-1998/0 Inhibitors of Formation of Protease Resistant Prion Protein 12/1/2003 E-276-2003/0 HIV-Dependent Expression Vector 11/1/2003 E-086-1999/0 6,875,855 7,332,167 Molecular Diagnosis of Disseminated Candida albicans Infection Using Hemoglobin-Response Gene 11/1/2003 E-072-2001/0 7,119,193 Identification of New Small RNAs and ORFs 11/1/2003 E-285-2002/0 7,485,306 Lutozmyia longipalpis Polypeptides and Methods of Use 11/1/2003 E-223-2002/0 Factors That Bind Intestinal Toxins 9/1/2003 E-150-1994/0 5,622,861 Hepatitis A Virus Receptor And Methods Of Use 1/1/2003 E-144-2002/0 E-144-2002/1 7,566,451 vel Broadly Cross-Reactive HIV Neutralizing Human Monoclonal Antibodies Selected from Fab Phage Display Libraries Using a Novel Strategy Based on Alternative Antigen Panning and Novel Broadly Cross-Reactive HIV-1 Neutralizing Human Single-Chain Antibodies Derived from X5 by DNA Shuffling and Alternating Antigen Panning 11/1/2002 E-317-2001/0 Discovery of Novel Inhibitors of HIV-1 Integrase That Can Be Used for the Treatment of Retroviral Infection Including AIDS 2/1/2002 E-242-2001/0 Strategies to Destabilize the Active HIV-1 Protease Dimer Resulting in Stable Monomer Formation 1/1/2002 E-064-2001/0 6,951,761 Parallel Measurements of Multiple Macromolecules Using a Cryoarray 11/1/2001 E-304-1998/0 Recombinant Proteins of the Swine Hepatitis E Virus and Their Uses as a Vaccine and Diagnostic Reagents for Medical and Veterinary Applications 9/1/2001 E-179-2001/0 Identification of a Cell-surface Receptor for Papillomaviruses 2/1/2001 E-082-1996/0 Simian-Human HAV Chimeras Encoding a Hepatitis A Virus Having a Chimeric 2C Protein 1/1/2001 E-125-1988/0 5,529,904 Adhesion Molecules (Carbohydrate Receptors) For Pathogenic Bacteria And Fungi 4/1/2000 E-200-1993/0 E-200-1993/1 6,039,957 6,171,596 Oligomeric HIV-1 Envelope Glycoproteins 6/1/1999 E-092-1988/0 Immunologically Active Peptides From The HIV Envelope Protein Eliciting Both Antibody And T Cell Responses 2/1/1999 E-034-1989/0 Probe To Identify Enteroinvasive E. coli And Shigella Species 9/1/1998 E-141-1992/2 6,207,416 6,787,145 Recombinant Proteins Of A Pakistani Strain Of Hepatitis E And Their Use In Diagnostic Methods And Vaccines 7/1/1998 E-276-1988/1 5,674,720 Design And Construction Of Non-Infectious Human Retroviral Mutants Deficient In Genomic RNA 6/1/1998 E-196-1989/0 6,423,835 Nucleotide, Deduced Amino Acid Sequence, Isolation And Purification Of Heat-Shock Chlamydial Proteins 6/1/1998 E-003-1989/0 5,869,608 6,384,206 Nucleotide And Amino Acid Sequences Of The Four Variable Domains Of The Major Outer Membrane Proteins Of Chlamydia Trachomatis 3/1/1998 E-209-1997/0 6,600,030 Delayed Progression To AIDS By A Missense Allele Of The CCR2 Gene 3/1/1998 E-087-1997/0 STRL33, A Human Fusion Accessory Factor Associated With HIV Infection 10/1/1997 E-056-1990/1 5,470,712 5,780,041 Antigenic Protein Of Borrelia Burgdorferi 10/1/1997 E-059-1990/0 6,709,811 Versatile Reagent For Detecting Murine Leukemia Viruses 5/1/1997 E-019-1993/0 5,449,608 Parvovirus B19 Receptor And Parvovirus B19 Detection 4/1/1996 E-454-1986/3 5,604,093 Human B Lymphotropic Virus (HBLV) Isolation And Products 5/1/1995 E-134-1994/0 Hepatitis C Virus Core Peptide For Stimulation Of Cytotoxic T Lymphocytes 5/1/1995 E-032-1994/0 5,882,852 7,070,790 Nucleotide And Deduced Amino Acid Sequences Of The Envelope-1 And Core Genes Of Isolates Of Hepatitis C Virus And Methods Of Use 11/1/1994 E-325-1983/2 5,516,630 Production Of Complementary DNA Representing Hepatitis A Viral Sequences By Recombinant DNA Methods And Uses Therefor 11/1/1994 E-076-1992/0 Clones Encoding Mammalian ADP-Ribosylarginine Hydrolases 2/1/1994 E-032-1990/1 5,403,718 Method For Immune Capture And Primary Isolation Of Borrelia Burgdorferi 2/1/1994 E-226-1989/0 5,489,511 Specific And Sensitive Diagnostic Test For Lyme Disease 1/1/1994 E-253-1993/0 5,437,951 5,709,996 5,716,620 5,744,142 5,756,284 5,871,998 5,985,610 7,220,419 7,361,356 Self-Assembling Recombinant Papillomavirus Capsid Proteins Back

Note that this site uses cookies, Click here for more information.